Is OMER or ORIC more undervalued in 2026?

CirclFi compares Omeros Corporation (OMER) and Oric Pharmaceuticals, Inc. (ORIC) using 13 institutional-grade valuation models. OMER has a Quality of Company score of 3.3/10 while ORIC scores 4.7/10.

Which is a better buy — OMER or ORIC?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do OMER and ORIC valuations compare?

OMER at $11.15 and ORIC at $8.45 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

OMER vs ORIC Valuation Comparison 2026 — Intrinsic Value Analysis

OMER

Biotechnology

Omeros Corporation

Quality

3.3

out of 10

Value Trap

LOW

Price

$11.15

Last close

Models

10/13

Active

ORIC

Biotechnology

Oric Pharmaceuticals, Inc.

Quality

4.7

out of 10

Value Trap

SAFE

Price

$8.45

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	OMER Fair Value	OMER Upside	ORIC Fair Value	ORIC Upside
Bayesian DCF	Intrinsic	$2.45	-78.0%	$2.50	-70.4%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$3.03	-72.8%	$3.62	-57.1%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for OMER vs ORIC — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

OMER vs ORIC — Which Stock Is More Undervalued?

ORIC scores higher with a 4.7/10 quality rating vs OMER's 3.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Omeros Corporation (OMER) and Oric Pharmaceuticals, Inc. (ORIC) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

OMER currently trades at $11.15 with a QOC of 3.3/10, while ORIC trades at $8.45 with a QOC of 4.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).